Tickerover
Healthcare

CNC Stock Analysis

Centene Corporation · current price $64.77 (-0.87% today)

Solid setup — 4/4 EPS beats. Momentum, fundamentals and macro indicators are aligned.
★★★★
Quality
📊

The six-pillar scorecard

Momentum
63
Drifting higher
price trend
Growth
25
Barely growing
sales & profit growth
Quality
52
Solid fundamentals
profitability & balance sheet
Valuation
80
Looks cheap
is the price fair?
Sentiment
37
Mixed views
analyst & crowd mood
Risk
61
Moderate risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
1-month momentum1-month momentum: 6262Relative strengthRelative strength: 8585RSI zoneRSI zone: 7070Earnings qualityEarnings quality: 9393GrowthGrowth: 4040FundamentalsFundamentals: 7777Breakout proximityBreakout proximity: 6363
Margin profileWhat survives each step down the income statement.
GrossGross: 11.4%11.4%OperatingOperating: 3.8%3.8%NetNet: -2.8%-2.8%Free cash flowFree cash flow: 5.0%5.0%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +132.6% vs estimate+133%2026-062026-03: +57.9% vs estimate+58%2026-032025-12: +2.5% vs estimate+2%2025-122025-09: +404.3% vs estimate+404%2025-09
👁

Hype Check

Reading CNC’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading CNC’s filings…

📣

Latest earnings

LAST EARNINGS Centene Corporation (CNC)

Latest earnings

EPS
$0.50 vs $-0.16 est · +404.3% vs estimate BEAT
Revenue
$53.58B · +7.8% YoY
Stock reaction (1M)
+6.4%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
12.2×
Forward P/E
12.2×
PEG
0.89
Price / Sales
0.2×
Price / Book
1.4×
EV / EBITDA
4.6×
Analyst target
$71.67
Target range
$56.00 – $85.00
Implied upside
+10.6%
🩺

Financial health

Gross margin
11.4%
Operating margin
3.8%
Net margin
-2.8%
FCF margin
5.0%
Return on equity
-20.4%
Debt / equity
0.71
Revenue growth YoY
+4.6%
📈

Technicals

$28.2452-week range$69.36
RSI (14)
49
50-day MA
$65.21
200-day MA
$49.58
ATR (14)
1.97
Beta
1.10
1-month return
+6.4%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$0.50$-0.16+404.3%Beat
2025-12-31$-1.19$-1.22+2.5%Beat
2026-03-31$3.37$2.13+57.9%Beat
2026-06-30$2.51$1.08+132.6%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.03%
Beta
1.10
📰

Latest news on CNC

🔗

Similar stocks in Healthcare

Frequently asked

What is CNC's Quant Score?

Centene Corporation (CNC) currently has a TickerMover Quant Score of 62/100, rated ★★★★ Quality. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is Centene Corporation (CNC) a buy?

TickerMover does not give buy or sell recommendations. CNC scores 62/100 (★★★★ Quality) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is CNC's score updated?

CNC's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for CNC →